v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Apr. 30, 2026
Apr. 30, 2025
Operating activities    
Net Income (Loss) $ (138,872) $ (12,628)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities    
Depreciation and amortization 11,189 11,082
Stock-based compensation, net of capitalized cost of $455 and $673, respectively 16,461 12,542
Change in fair value of warrant liabilities 106,474 (10,387)
Change in fair value of contingent consideration 0 (41)
Other (331) 1,229
Changes in operating assets and liabilities    
Accounts receivable 22,466 (21,185)
Inventories (731) 0
Prepaid expenses and other assets (3,357) 1,254
Accounts payable, accrued and other liabilities 4,081 (8,915)
Deferred revenue (1,143) 42,072
Deferred hosting costs (797) 2,323
Net cash provided by operating activities 15,440 17,346
Investing activities    
Purchases of property and equipment (17,310) (8,119)
Capitalized internal-use software (647) (1,225)
Maturities of available-for-sale securities 37,487 11,123
Sales of available-for-sale securities 44,525 582
Purchases of available-for-sale securities (33,367) 0
Purchases of licensed imagery intangible assets (274) (621)
Net cash provided by investing activities 30,414 1,740
Financing activities    
Proceeds from the exercise of common stock options 3,552 2,962
Payments for withholding taxes related to the net share settlement of equity awards (17,340) (5,264)
Proceeds from employee stock purchase program 1,328 346
Payments of contingent consideration for business acquisitions 0 (4,820)
Proceeds from the exercise of warrants 107,801 0
Other (138) (2,383)
Net cash provided by (used in) financing activities 95,203 (9,159)
Effect of exchange rate changes on cash and cash equivalents, and restricted cash and cash equivalents (1,015) 5,683
Net increase in cash and cash equivalents, and restricted cash and cash equivalents 140,042 15,610
Cash and cash equivalents, and restricted cash and cash equivalents at the beginning of the period 235,554 129,994
Cash and cash equivalents, and restricted cash and cash equivalents at the end of the period $ 375,596 $ 145,604